J 2003

Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.

REKTOROVÁ, Irena, Ivan REKTOR, Martin BAREŠ, V. DOSTÁL, Edvard EHLER et. al.

Basic information

Original name

Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.

Authors

REKTOROVÁ, Irena (203 Czech Republic, guarantor), Ivan REKTOR (203 Czech Republic), Martin BAREŠ (203 Czech Republic), V. DOSTÁL (203 Czech Republic), Edvard EHLER (203 Czech Republic), Zuzana FANFRDLOVÁ (203 Czech Republic), Jiří FIEDLER (203 Czech Republic), Hana KLAJBLOVÁ (203 Czech Republic), P. KULIŠŤÁK (203 Czech Republic), Pavel RESSNER (203 Czech Republic), J. SVÁTOVÁ (203 Czech Republic), Karel URBÁNEK (203 Czech Republic) and Jana VELÍSKOVÁ (203 Czech Republic)

Edition

European Journal of Neurology, Oxford, Blackwell Science, 2003, 1351-5101

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.000

RIV identification code

RIV/00216224:14110/03:00009457

Organization unit

Faculty of Medicine

UT WoS

000183687100009

Keywords in English

depression;dopamine receptor agonists;Parkinson's disease

Tags

Změněno: 26/6/2009 15:58, prof. MUDr. Irena Rektorová, Ph.D.

Abstract

V originále

An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole as add-on to L-dopa therapyon depression in 41 non-demented patients suffering from both mild or moderate depression and advanced Parkinson's disease.